Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(60.0%)
Phase 1
4(40.0%)
10Total
N/A(6)
Phase 1(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT06740864Not ApplicableCompleted

40 Hz Transcranial Alternating Current Stimulation for Inducing Gamma Oscillations

Role: lead

NCT06165445Not ApplicableCompleted

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Role: lead

NCT06155786Not ApplicableCompleted

Cognitive Effects of tDCS and tRNS in Schizophrenia

Role: lead

NCT06680154Not ApplicableCompleted

Induction and Stabilization of Gamma Oscillations With 40 Hz External Brain Stimulation

Role: lead

NCT05501132Phase 1Completed

Efficacy of Intensified Transcranial Direct Current Stimulation in Obsessive-compulsive Disorder

Role: lead

NCT06401928Not ApplicableCompleted

Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Sclerosis

Role: lead

NCT06974136Not ApplicableRecruiting

tES Modalities for the Treatment of ADHD

Role: lead

NCT05200962Phase 1Unknown

Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI Study

Role: lead

NCT05491720Phase 1Completed

Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum Disorder

Role: lead

NCT05342727Phase 1Completed

Transcranial Direct and Alternating Stimulation of the Prefrontal Cortex for Cognitive Improvement in Schizophrenia

Role: lead

All 10 trials loaded